Navigation Links
BioForm Medical to Announce Financial Results For Quarter Ended March 31, 2008, Third Quarter of Fiscal 2008, and Host Conference Call and Webcast on May 1, 2008
Date:4/10/2008

SAN MATEO, Calif., April 10 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced that on Thursday, May 1, 2008, it will report its financial results for the quarter ended March 31, 2008, which is its third quarter fiscal year 2008. The Company will issue the earnings press release after the NASDAQ Global Market closes and will hold a conference call with investors at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).

BioForm Medical Chief Executive Officer Steve Basta and Chief Financial Officer Derek Bertocci will discuss the Company's results for the quarter ended March 31, 2008. The conference call will be webcast live on the Investor Relations section of BioForm Medical's website at http://www.bioform.com. The online archive of the broadcast will be available approximately 90 minutes after the live call and will continue to be available for four weeks.

The conference call may be accessed by dialing 877-591-4956 for callers in the U.S. and 719-325-4880 for international callers. Please notify the operator that you would like to join "BioForm Medical's Third Quarter Earnings Call" and provide the participant code "7284989", if prompted.

About BioForm Medical, Inc.:

BioForm Medical, Inc. is a medical aesthetics company headquartered in San Mateo, California. BioForm is dedicated to bringing doctors and their patients safe and effective products for use in the dermatology, plastic surgery and ENT markets. BioForm's products include Radiesse(R), a long-lasting filler for use in facial aesthetics and vocal fold insufficiency, and Coaptite(R) for treating female stress urinary incontinence which is marketed through a partnership with Boston Scientific Corporation. BioForm has licensed U.S. marketing rights to Aethoxysklerol(R), the worldwide leading sclerotherapy agent, which is currently being evaluated in a Phase III clinical trial. BioForm has also licensed BioGlue, a new surgical adhesive product for plastic surgery applications, which is being developed in a partnership with CryoLife, Inc.

Contact:

Adam Gridley

650.286.4025

Vice President, Corporate Development

BioForm Medical, Inc.


'/>"/>
SOURCE BioForm Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. BioForm to Announce First Quarter Fiscal 2008 Financial Results and Host Conference Call and Webcast on December 13, 2007
2. BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008
3. MSU engineering team designs innovative medical device
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
6. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
9. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
10. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
11. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... With long-term experience in ... of Business Intelligence and Informatics, effective immediately. http://www.fluidedgeconsulting.com , As a ... a healthcare business and financial strategist for over 20 years. By leveraging ...
(Date:5/25/2016)... (PRWEB) , ... May 26, 2016 , ... The United ... treatment of androgenetic alopecia in both men and women. To date, the company is ... with FDA clearance for any adult who suffers with androgenetic alopecia. , “This ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... Association's Get With The Guidelines®-Stroke Gold Plus Achievement Award with Target: StrokeSM ... Memorial Healthcare System, recognizes its commitment to emergency stroke care to ensure ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... and Tennessee locations to streamline patient check-in and post visit surveys. , “The ... to patient care. It has revolutionized the check-in process for our clinic network, ...
(Date:5/25/2016)... ... May 25, 2016 , ... Furthering its position as the industry leader in ... Drug Free Sport (Drug Free Sport®) is excited to expand on details of its ... 12 – 13 in Kansas City, MO, will gather sports industry professionals to examine, ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 24, 2016 Dutch surgeons have launched a ... the world and treat patients on a global scale. Medical professionals ... Asia and the US have already signed ... and networking in a totally secure environment. Education  ... zone working together with a surgeon at Harvard to treat a ...
(Date:5/23/2016)... , May 23, 2016 Global ... 163 pages, profiles 12 companies and the Paclitaxel analysis ... figures on the industry and its players. ... comprehensive in nature, details the current state of the ... including definitions, classifications, applications and industry chain structure. The ...
(Date:5/23/2016)... , May 23, 2016 ... Size, Share, Development, Growth and Demand Forecast to ... and Other), by Application (Drug Discovery and Development, ... Users (Pharmaceuticals, Life Science and Biotechnology, Academic and ... Market Research, the global mass spectrometry market ...
Breaking Medicine Technology: